Protective Efficacy of Centralized and Polyvalent Envelope Immunogens in an Attenuated Equine Lentivirus Vaccine

Authors

Jodi K. Craigo, University of Pittsburgh
Corin Ezzelarab, University of Pittsburgh
Sheila J. Cook, University of KentuckyFollow
Chong Liu, University of Kentucky
David Horohov, University of KentuckyFollow
Charles J. Issel, University of KentuckyFollow
Ronald C. Montelaro, University of Pittsburgh

Abstract

Lentiviral Envelope (Env) antigenic variation and related immune evasion present major hurdles to effective vaccine development. Centralized Env immunogens that minimize the genetic distance between vaccine proteins and circulating viral isolates are an area of increasing study in HIV vaccinology. To date, the efficacy of centralized immunogens has not been evaluated in the context of an animal model that could provide both immunogenicity and protective efficacy data. We previously reported on a live-attenuated (attenuated) equine infectious anemia (EIAV) virus vaccine, which provides 100% protection from disease after virulent, homologous, virus challenge. Further, protective efficacy demonstrated a significant, inverse, linear relationship between EIAV Env divergence and protection from disease when vaccinates were challenged with viral strains of increasing Env divergence from the vaccine strain Env. Here, we sought to comprehensively examine the protective efficacy of centralized immunogens in our attenuated vaccine platform. We developed, constructed, and extensively tested a consensus Env, which in a virulent proviral backbone generated a fully replication-competent pathogenic virus, and compared this consensus Env to an ancestral Env in our attenuated proviral backbone. A polyvalent attenuated vaccine was established for comparison to the centralized vaccines. Additionally, an engineered quasispecies challenge model was created for rigorous assessment of protective efficacy. Twenty-four EIAV-naïve animals were vaccinated and challenged along with six-control animals six months post-second inoculation. Pre-challenge data indicated the consensus Env was more broadly immunogenic than the Env of the other attenuated vaccines. However, challenge data demonstrated a significant increase in protective efficacy of the polyvalent vaccine. These findings reveal, for the first time, a consensus Env immunogen that generated a fully-functional, replication-competent lentivirus, which when experimentally evaluated, demonstrated broader immunogenicity that does not equate to higher protective efficacy.

Document Type

Article

Publication Date

1-8-2015

Notes/Citation Information

Published in PLOS Pathogens, v. 11, no. 1, article e1004610, p. 1-14.

© 2015 Craigo et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Digital Object Identifier (DOI)

http://dx.doi.org/10.1371/journal.ppat.1004610

Funding Information

This work was supported by NIH/NIAID (http://www.niaid.nih.gov) grant RO1 AI25850. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Repository Citation

Craigo, Jodi K.; Ezzelarab, Corin; Cook, Sheila J.; Liu, Chong; Horohov, David; Issel, Charles J.; and Montelaro, Ronald C., "Protective Efficacy of Centralized and Polyvalent Envelope Immunogens in an Attenuated Equine Lentivirus Vaccine" (2015). Maxwell H. Gluck Equine Research Center Faculty Publications. 2.
https://uknowledge.uky.edu/gerc_facpub/2